Gene therapies have emerged as promising treatments in clinical development for various
retinal disorders, offering hope to patients with inherited degenerative eye conditions …

Variants within the Retinitis Pigmentosa GTPase regulator (RPGR) gene are the
predominant cause of X-Linked Retinitis Pigmentosa (XLRP), a common and severe form of …

The most common inherited eye disease is retinitis pigmentosa (RP). X-linked RP (XLRP) is
one of the most severe types of RP, with a considerable disease burden. Patients with XLRP …

X-linked retinitis pigmentosa (XLRP) is a rare inherited retinal disease manifesting as
impaired night vision and peripheral vision loss that progresses to legal blindness. Although …

X-linked retinitis pigmentosa (XLRP) is a severe inherited retinal degenerative disease
characterized by progressive loss of photoreceptors and retinal pigment epithelium, leading …

Objectives X-linked retinitis pigmentosa (XLRP) is a rare inherited retinal disease with no
available treatment. Gene therapies in clinical trials will pose challenges for health …

A 60-year-old woman underwent vitrectomy and internal limiting membrane (ILM) peeling for
a primary macular hole. To enhance visualization, we applied Brilliant Blue dye meticulously …

ADVM-022, developed by Adverum Biotechnologies, is an innovative gene therapy aimed at
treating wet age-related macular degeneration (AMD). This therapy employs a novel …

Gene therapy, a pivotal advancement in modern medicine, particularly shines in
ophthalmology. By targeting defective genes with engineered vectors, this approach …